Next Article in Journal
Inorganic Polymeric Materials for Injured Tissue Repair: Biocatalytic Formation and Exploitation
Next Article in Special Issue
p53 and Its Isoforms in Renal Cell Carcinoma—Do They Matter?
Previous Article in Journal
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
Previous Article in Special Issue
Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials
 
 
Review

Article Versions Notes

Biomedicines 2022, 10(3), 657; https://doi.org/10.3390/biomedicines10030657
Action Date Notes Link
article pdf uploaded. 11 March 2022 15:28 CET Version of Record https://www.mdpi.com/2227-9059/10/3/657/pdf-vor
article xml file uploaded 12 March 2022 13:59 CET Original file -
article xml uploaded. 12 March 2022 13:59 CET Update https://www.mdpi.com/2227-9059/10/3/657/xml
article pdf uploaded. 12 March 2022 13:59 CET Updated version of record https://www.mdpi.com/2227-9059/10/3/657/pdf
article html file updated 12 March 2022 14:00 CET Original file -
article html file updated 13 March 2022 09:58 CET Update -
article html file updated 1 August 2022 05:18 CEST Update https://www.mdpi.com/2227-9059/10/3/657/html
Back to TopTop